NCT00315640

Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation

A Study of the Safety and Efficacy of Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 70 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of anecortave acetate depot when administered for the treatment of elevated IOP following treatment with steroids.

Conditions

• Eye Diseases

Interventions

Type	Name	Description
DRUG	Anecortave Acetate Sterile Suspension, 6 mg/mL	One 0.5 mL anterior juxtascleral depot (AJD) injection in the study eye
DRUG	Anecortave Acetate Suspension Depot, 30 mg/mL	One 0.5 mL anterior juxtascleral depot (AJD) injection in the study eye
DRUG	Anecortave Acetate Sterile Suspension, 60 mg/mL	One 0.5 mL anterior juxtascleral depot (AJD) injection in the study eye
OTHER	Anecortave Acetate Vehicle	One 0.5 mL anterior juxtascleral depot (AJD) injection in the study eye

Timeline

• Start date: 2005-12-01
• Primary completion: 2009-07-01
• Completion: 2009-07-01
• First posted: 2006-04-19
• Last updated: 2012-11-28

Locations

12 sites across 8 countries: United States, Brazil, Hungary, Italy, Netherlands, Puerto Rico, Spain, United Kingdom